Clinical Trial Update: A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ezetimibe (SCH 58235) added to ongoing statin therapy in adults with primary hypercholesterolemia, known coronary heart disease, or mul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: Organon and Co | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: COMPLETED